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In the United States, the current cases of Alzheimer’s disease will double by 2050.
Therefore, it is important to study risk factors associated with dementia such as sleep duration.
This meta-analysis was conducted to understand the discrepancy in study results since some
demonstrated a V shaped association between duration of sleep and dementia while others
found no association. If there truly is an association then sleep duration could be targeted to
decrease the burdens caused by dementia.
A meta-analysis of published studies was conducted to assess the association between
sleep duration and the different forms of dementia. The articles were found using PubMed,
Embase, Scopus, and EBSCO with the search terms (“Sleep Duration” OR “Change in Sleep
Duration”) AND (Alzheimer* OR Dementia) and reviewing bibliographies. Studies were
included in the analysis if they met the following criteria 1) a longitudinal study 2) a cohort,
case-control, or clinical trial 3) assessed the exposure and outcome of interest 4) diagnosed
dementia using established diagnostic criteria 5) provided a risk estimate and 95% confidence
interval (CI) 6) in English 7) a published paper. Analyses such as test of heterogeneity,
sensitivity analysis, and tests of publication bias were done using STATA15.
The analysis included 11 cohort studies with a total of 48,360 participants. No significant

association was found between short or long sleep duration and any form of dementia.
However, there was a significant association between increase in sleep and dementia but there
were only two published papers that examined this association. This study suggests that there is
likely no association between sleep duration and any form of dementia which differs from
results of previous meta-analyses.
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BACKGROUND

Dementia is a general disease category used to describe degenerative brain diseases,
such as Alzheimer’s disease and vascular dementia, which affect the elderly population
(Gatz, et al., 2010). While the risk of Alzheimer’s disease is only 8-10% in those age 60-69
years old it triples to 33-38% at age 80 years for those who are carriers of the apolipoprotein
E (APOE) 4allele, the genetic variant that has been associated with an increased risk of
Alzheimer’s disease (Rasmussen, et al., 2018). Alzheimer’s disease is characterized by a
steady decline of memory and cognitive ability to the point that it interferes with daily
activity, while the biological characteristics are the accumulation of extracellular betaamyloid plaques and tau proteins in the brain. Vascular dementia differs from other forms of
dementia because there must be evidence that the cognitive decline is due to vascular
changes such as stroke (American Psychiatric Association, 2013). Those with vascular
dementia are more likely to live with more activities of daily living limitations than those
with Alzheimer’s disease (Gure, et al., 2009). While there are several biomarkers and
imaging techniques that can be used in the research setting to help diagnose dementia a
definite confirmation can only be done after death by dissecting the brain (Scheltens, et al.,
2016).
In the United States, it is estimated that there are around 5.7 million cases of dementia
with 60-70% of cases being categorized as Alzheimer’s disease dementia and 5-10% of cases
being categorized as vascular dementia. Due to the increase in life expectancy, it is expected
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that the number of people with dementia or Alzheimer’s disease will double to around 13.8
million in 2050 (Hebert, et al., 2013).
Unfortunately, since there is no cure for dementia it is ultimately fatal. In 2014,
Alzheimer’s disease was the sixth leading cause of death in the United States with a mortality
rate of 25.4 deaths per 100,000 people. (Taylor, et al., 2017). As a result, it is important to
study and validate risk factors that could potentially be targeted to reduce the risk for
dementia. There are several known modifiable risk factors for dementia such as being
diabetic (Akomolafe, et al., 2006), obese (Whitmer, et al., 2007), having hypertension
(Skoog, et al., 1996), a history of cardiovascular disease (Eriksson, et al., 2010), and low
education (Gatz, et al., 2007). Recently, the role of sleep has been gaining attention as a
potential risk factor for cognitive disorders.
Sleep has become a behavioral risk factor of interest because around one third of
adults report having sleep issues such as experiencing symptoms of insomnia, abnormal sleep
durations, and non-restorative sleep, making this a relatively common risk factor in the
United States (Morin, et al., 2006). The elderly population is the most likely to complain
about sleep disturbances, with the highest reported prevalence estimated at 70% (Jaussent, et
al., 2011). It has become a risk factor of interest for dementia and Alzheimer’s disease since
around 45% of those with the disease have a type of sleeping disturbance and 25-44% have a
type of sleeping disorder (Morin, et al., 2006). The development of sleeping disorders and
changes in sleep patterns are part of the natural aging process just like cognitive decline.
Thus, researchers have been trying to understand if they simply co-exist with one another or
if one precedes the other. (Shi, et al., 2018).
2

The relationship between sleep duration and dementia has been gaining attention.
This is because earlier studies have linked short and long duration of sleep to risk factors
associated with dementia such as cardiovascular disease (Cappuccio, et al., 2011), diabetes
mellitus (Gottlieb, et al., 2005), and obesity (Gangwish, et al., 2005). There are several
studies that have demonstrated a V shaped association between duration of sleep and
cognitive disorders such as dementia or Alzheimer’s disease. This suggests that elderly
individuals who have longer or shorter duration of sleep are more likely to develop a
cognitive disorder than those who have average duration of sleep. (Chen, et al., 2015)
However, there are some studies which only found an association for short duration of sleep
(Potvin, et al., 2012), others only found an association for long duration of sleep (BenitoLeon, et al., 2009), and some even observed no association (Luojus, et al., 2017) between
duration of sleep and cognition. The direction of effect is also not consistent with some
studies finding that shorter duration of sleep was protective for dementia (Sindi, et al., 2009).
Review of Prior Studies
There are currently only three meta-analyses published, with the most recent of these
published in 2018 and including articles through 2017 (Kim, et al., 2016: Liang & Ling-Bo &
Hao, 2018: Wu & Sun & Tan, 2018). The methods of measuring duration of sleep in
published studies is through self-report or questionnaires. Dementia and Alzheimer’s disease
were normally measured based on standardized criteria such as the Diagnostic and Statistical
Manual of Mental Disorders, Fourth Edition (DSM-IV) (Wu & Sun & Tan, 2018). The
DSM-IV defines dementia of the Alzheimer’s type as the gradual development of cognitive
deficits that include both types of memory impairment (ability to learn new material or recall
3

previous knowledge) and one type of cognitive disturbance: language disturbance, impaired
ability to perform motor activity, failure to recognize objects, and disturbance in executive
functioning such as planning or organizing. These deficits must result in an extreme
impairment in social or occupational functioning which is a significant decline from the
previous level of functioning and does not occur exclusively during delirium. To be
categorized as Alzheimer’s disease dementia other disorders such as major depressive
episode and schizophrenia must be accounted for to make sure they cannot explain the
symptoms. Features that separate Alzheimer’s disease from other dementias are that it cannot
be due to other central nervous system conditions such as Parkinson’s disease or
cerebrovascular disease which can result in deficits in memory and cognition. It also cannot
be due to substance-induced conditions or due to other systemic conditions that can cause
dementia such as hypothyroidism and vitamin B deficiency (American Psychiatric
Association, 2000). While the most recent version of the DSM (DSM-5) was published in
2013 it is not likely to have been be used by the longitudinal studies in this meta-analysis
(American Psychiatric Association, 2013).
A new meta-analysis should be done because the previous meta-analyses focused on
the relationship between duration of sleep and cognitive decline (Liang & Ling-Bo & Hao,
2018) or mild cognitive impairment (MCI) combined with dementia (Kim, et al., 2016: Wu
& Sun & Tan, 2017). MCI is defined as the pre-clinical stage of dementia where an
individual experiences slight impairment in one or more cognitive domains such as memory
or language, but the person is still able to function independently. This differs from dementia
where these cognitive domains must be impaired to the point that there is interference with
4

daily life. MCI can be diagnosed by an episodic memory test such as the word-list learning
tests and by clinical judgment (Albert, et al., 2011). There has not been a meta-analysis
which only includes studies that looked at dementia without MCI which may lead to different
outcomes. This could occur because while people with MCI are more likely to develop
dementia there are some individuals with MCI who return to normal cognition or remain
mildly cognitively impaired (Kantarci, et al., 2009). These previous meta-analyses also did
not examine the relationship between change in duration of sleep and risk for dementia which
is a growing body of research. As a result, a more recent meta-analysis to improve our
understanding of the association between Alzheimer’s disease and sleep duration is needed.
Public Health Significance
If there truly is a causal association between abnormal sleep duration and cognitive
decline, then sleep duration could be an important modifiable risk factor that could be
targeted to improve the quality of life for the elderly (Youngstedt & Kripke, 2004). This
could potentially be important information for public health programs because the percent of
United State citizens who sleep 6 or less hours per day has increased from 28.6% in 2004 to
32.9% in 2017. This corresponds to around 9 million adults and could lead to an increase of
dementia cases if the association with short sleep duration holds true (Sheehan, et al., 2018).
As a result, it is important to study why differences in study results have arisen.
Hypothesis, Research Question, Specific Aims or Objectives
The specific purpose of this study will be to expand the current understanding of the
association between sleep and dementia to see if some consistency can be found in the
conflicting studies. This was done by 1) performing a literature search to include publications
5

beginning from inception to January 2019 to try to increase statistical power; 2) generating
summary effect measures for studies that have homogeneous results; and 3) identifying
factors that could explain variation in effect measures across studies.
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METHODS
Study Design
This study was a meta-analysis that followed the guidelines set by Preferred
Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) (Moher, et al., 2009).
The unit of analysis was each individual publication.
Literature Search
The articles were found by searching PubMed
(https://www.ncbi.nlm.nih.gov/pubmed/), Embase (https://www.embase.com/) , Scopus
(https://www.scopus.com) , and EBSCO (https://origin.ebsco.com/). In all four databases
articles were identified by matching the articles’ title, keywords, and abstract to the following
search terms: (change* in sleep duration” or “Sleep Duration”) and (Alzheimer* or
dementia). The literature search included studies published up to January 20th 2019. In
Embase, the exposure and outcome variables were searched separately then combined. The
search term “Sleep time” was added for the exposure because it was a keyword that was
specific to Embase and not used in PubMed and Scopus. The results were then limited by
using the result filter for publication types which limited the results to “Articles”. The results
were also refined in Scopus and EBSCO by limiting the document type to “Article”. There
were no restrictions when searching for papers using PubMed. The papers from previous
meta-analyses that follow the eligibility criteria, stated below, were also included. Duplicates
were removed by using the citation manger RefWorks.
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Data Collection:
Two investigators independently selected the articles based on the following inclusion
and exclusion criteria. Titles and abstracts were scanned to determine if they met the
following eligibility criteria.

Inclusion Criteria
The articles included in the meta-analysis met the following inclusion criteria: 1)
described a longitudinal study to allow the assessment of temporality 2) described the use of
the following study designs: cohort, case-control, or clinical trial 3) assessed the relationship
between the exposures sleep duration or change in sleep duration and the outcomes
Alzheimer’s disease or dementia 4) diagnosed Alzheimer’s disease or dementia based on an
established diagnostic criteria such as DSM-IV, medical records, or linkage to a national
registry 5) provided enough data to calculate odds ratios (ORs), rate ratios (RRs), or hazard
ratios (HRs) and the 95% confidence interval (CI) 6) the paper was written in English 7) the
papers must be a published journal article and not a conference abstracts or excerpts.
Exclusion Criteria
1) Studies that included participants with Parkinson’s disease at baseline and in the
outcome measure. This was done because sleep disorders (Chaudhuri & Schapira, 2009) and
dementia (Hely, 2008) are non-motor symptoms associated with Parkinson’s disease.
Another issue is that their level of cognition is different than the general population. 2) If the
study subject was an animal model 3) Studies that had an outcome measure for MCI and
dementia combined but not dementia independently 4) Studies that use napping duration as
8

the exposure of interest. This is because sleeping is fundamentally different from napping. 5)
Articles based on a pilot study, when an article describing the full study is available.
Quality Assessment
Two investigators used the Newcastle-Ottawa quality assessment scale to
independently perform the quality assessment. This assessment scale will be used since there
are likely no clinical trials on this topic and because it was used by the previous three metaanalyses (Kim, et al., 2016: Liang & Ling-Bo & Hao, 2018: Wu & Sun & Tan, 2017).This
assessment scale has a maximum score of 9 stars and assesses quality based on the selection
of cases and controls which has a maximum score of 4 stars and comparability of cases and
controls which contributes a maximum of 2 stars. For case-control studies the quality is also
based on the ascertainment of the exposed and non-exposed as well as the non-response rate
which all contribute a maximum of 3 stars. For cohort studies, the quality is based on the
assessment of outcome, the time of follow up, and adequacy of follow up which contribute a
maximum of 3 stars (Wells, et al., 2012). Disagreements on the score of each paper were
settled by the investigators discussing their results to reach an agreement on the final score.
There is currently no official threshold but a quality score of 0-3 stars will be considered low
quality, 4-6 stars will be considered moderate quality, and 7-9 stars will be considered high
quality (Liang & Ling-Bo & Hao, 2018).
Data Extraction:
Two investigators independently read the papers and extracted the variables of
interest. The study characteristics: year of study, location of study (country), study design
(case-control, retrospective cohort, prospective cohort or clinical trial), number of
9

participants, percent of male participants, percent of drop outs, the confounders that were
adjusted for and how they were measured, how the study handled cases of
dementia/Alzheimer’s disease which developed in the first few years after baseline, the
average age at baseline, the range of ages that was eligible for the study at baseline, duration
of follow-up, and the number and percent of each ethnicity were extracted. The variables
concerning the exposure: The cut-off for each category of sleep duration, the definition of
sleep duration (e.g., 24 hours or night time sleep duration), the method that was used to
measure duration of sleep, and number of participants in each sleep duration category were
extracted. For the exposure variable “change in sleep duration”: the categories for change in
sleep duration, time between previous sleep duration and current sleep duration, and number
of participants in each change in sleep duration category were extracted. The variables
concerning the outcome: the type of dementia (all cause dementia, Alzheimer’s disease,
vascular dementia), the method that was used to determine Alzheimer’s disease or dementia
and the number of cases and controls were extracted. The category dementia was labeled all
cause dementia if there were no other categories of dementia present in the results. This was
done to make the studies comparable and to reduce the number of outcome categories. The
risk estimate (OR, HR, or RR) that adjusted for the most variables and its corresponding 95%
confidence interval was also extracted. This was done because it can be assumed that
adjustment will result in the true risk estimate for the exposure and outcome, making the risk
estimates from different populations comparable even if they are obtained through different
study methods. If there were more than three categories of sleep duration, then the ORs of all
categories were kept. Sleep duration categories above the reference group were considered
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long duration of sleep and sleep duration categories below the reference category were
considered short duration of sleep. If the association between duration of sleep and dementia
at different times points was reported then the risk estimate for each time point as well as the
description of the time point was extracted. For the variable “Method of sleep ascertainment”
if the question is simply “how many hours do you sleep” then it will be assumed that it is a
24-hour period.

Data Analysis
All analyses were conducted using the software STATA version 15 (StataCorp,
College Station, TX, USA). A p-value that was equal to or less than 0.05 indicated that the
result was statistically significant. When analyzing the data, the effects of short duration of
sleep and long sleep duration on the outcome were assessed separately. The analysis was also
separated for the outcomes dementia, Alzheimer’s disease, and vascular dementia. This was
done to prevent a unit-of-analysis error since there were several studies that looked at more
than one subtype of dementia. As a result, if the analysis was not separated by outcome then
the participants in the control groups would be counted more than once in an analysis since
the same control group was used for each disease in one study. To maintain consistency, if
there were more than 3 categories of sleep duration, the risk estimate from the lowest
duration of sleep was used for assessment of short duration of sleep while the risk estimate
from the highest duration of sleep was used for long duration of sleep. In the main analyses,
if sleep was ascertained at two different ages in the same cohort, then the risk estimates for
sleep ascertainment at around age 65 will be used because most studies ascertained sleep
11

around that age. A forest plot was created to visually compare and present the summary
measures from each study. The effect measures OR, RR, HR and their 95% confidence
intervals were used to calculate the I2 to evaluate the level of agreement between the studies
(Higgins, et al., 2003).
The I2 was calculated under the fixed effects model for short duration of sleep
because there appeared to be homogeneity. It was used because all studies categorized sleep
in the same manner. The random effects model was used to assess long sleep duration since
there were clear differences in how the studies characterized sleep. For example, the risk
estimate used from Westwood et al. defined long sleep duration as 9 hours compared to less
than 9 hours. This differed from the definition of long duration of sleep from other studies
which compared the highest sleep category with the average category. While Westwood et al.
did have a risk estimate which defined long duration of sleep in a similar manner as other
studies it could not be used because it included participants with MCI at baseline. The
random effects model was also used to assess prolonged and reduced sleep duration because
there were very few studies, so they are not expected to include the true association.
The I2 statistic was used because it can be used for comparing studies with different
types of designs, outcome data, and sizes. The I2 values of 25%, 50%, and 75% were used to
respectively represent low, moderate, and high heterogeneity. Values above 50% suggested
statistical significance (Higgins, et al., 2003). Sensitivity analysis was performed to assess
the contribution of each individual study to the magnitude of the overall summary estimates.
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Publication Bias:
To assess publication, bias an Egger’s regression test and a funnel plot were created.
This was done because studies that suggests an association between the exposure and
outcome may be more likely to be published then those that suggest no association which
leads to publication bias. If no publication bias is present, then the plot should resemble a
symmetrical inverted funnel because the plot indicates that precision increases as the study
size increases. The Egger’s regression was also performed to validate the results from the
funnel plot since there is criticism that asymmetry could be due to factors besides publication
bias (Egger, et al., 1997). For example, greater effects may be seen in smaller intervention
studies because they are more likely to have greater compliance.
Meta-Regression and Subgroup Analysis
A meta-regression was performed using the following pre-set variables: study design,
sample size (less than 1000, 1000-3000, more than 3000), the number of sleep duration
categories (3 or 5), definition of sleep duration (24-hour period or nocturnal sleep), type of
cognitive disorder (dementia or Alzheimer’s disease), the number of cases (less than 500 or
greater than 500), race/ethnicity (white or non-white), gender (male, female, or both),
duration of follow up (less than 10 years, 10-19 years, or more than 20 years), age at baseline
(younger than 65 or 65 and older), if they excluded people who developed a cognitive
disorder after a certain number of years after baseline (yes or no), and the method of
assessing sleep duration (self-report or questionnaire). The demographic variable age was
chosen because the rate of dementia doubles every five years starting from age 65 (Evan, et
al., 1989), ethnicity was selected because those who are non-Caucasian are more likely to
13

develop dementia then those who are Caucasian (Tang, et al., 1998), and gender because
females are more likely to develop Alzheimer’s disease compared to men (Seshadri, et al.,
1997) while males are more likely to develop Lewy body dementia (Nelson et al., 2010).
This was done to discover if any of these factors significantly affect the association between
sleep duration and Alzheimer’s disease or dementia. However, the meta-regression should
not have been considered because there were less than ten studies in each meta-regression
(Higgins & Green, 2011).
After the study characteristics were abstracted, it was not possible to conduct a metaregression for study design since all the studies were cohort studies. There were several
studies that did not describe the race/ethnicity of their cohort, so the studies were analyzed by
the continent of the study cohort (Europe, Asia, or USA). The variables age of sleep
ascertainment (early midlife or late-life) and MCI at baseline (yes or no) were included in
further analysis. For age of sleep ascertainment, early mid-life was defined as obtaining data
on sleep before age 60. If the study had both early mid-life and late-life risk estimates then
the early mid-life was added to the analysis, so the analysis could reflect all findings. This
variable was included because there were studies that assessed sleep duration after age 60
while others assessed sleep around age 40 to 50. This subgroup was also included because
beta-amyloid accumulation, one of the hypothesized biological mechanisms for Alzheimer’s
disease, is believed to occur 20 years before the onset of dementia (Villemagne, et al., 2013).
Having mild cognitively impaired individuals at baseline was originally an exclusion
criterion. This is because a study found that shorter duration of sleep was protective for those
who were cognitively impaired while those that had normal cognition were at greater risk for
14

cognitive decline (Johar, et al., 2016). Unfortunately, only three (Hahn et al., 2014:
Westwood, et al., 2017: Bokenberger, et al., 2017) out of the eleven studies explicitly stated
that they stratified by baseline cognitive status to separate those who are cognitively intact
and those who are mild cognitively impaired. As a result, instead of only including these
three studies in the meta-analysis a subgroup analysis was conducted to determine if studies
that included MCI at baseline were more likely to have significant results than studies that
didn’t include MCI at baseline. This was done by obtaining a summary effect estimate from
studies that did not include MCI participants at baseline and a summary effect estimate from
studies that had MCI participants at baseline.

Human Subjects, Animal Subjects, or Safety Considerations
There was no data obtained from human subjects since this study was a meta-analysis
of published literature. The statistical analysis for this study was done using the effect
measures calculated from group data that were extracted from each individual study.
RESULTS
Literature Search

The initial literature search identified 371 papers from PubMed, 624 papers from
Embase, 20 from Scopus, 38 from EBSCO, and 28 citations from the previous three metaanalyses. (Kim, et al., 2016: Liang & Ling-Bo & Hao, 2018: Wu & Sun & Tan, 2017). After
removing the 217 duplicates there were 573 articles left. After screening the titles and
abstracts of the articles there were 48 articles left that were fully read to assess for eligibility.
The 525 publications were excluded because they were not in English, used an animal model,
15

were not an article, were a review, or they clearly did not have the outcome or exposure of
interest which made it irrelevant. Once this was completed, there were 11 studies left for
quantitative synthesis after 36 articles were excluded for including the dementia/MCI
outcome, being a cross-sectional study, or reporting dementia mortality without dementia
incidence. The results of the literature search are presented in Figure 1. These eleven studies
were considered high quality based on the Newcastle-Ottawa quality assessment scale.
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Figure 1. Results of the literature search. This flow diagram shows the process used to
determine the final studies from all the studies that were found in the literature
search.
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Study Characteristics
All 11 studies consisted of cohort studies from 2009 to 2018 and were considered
high quality by the independent investigators based on the Newcastle-Ottawa quality
assessment scale (Appendix F). These studies had an average follow-up time of 14.9 years
and a total of 48,360 participants. However, only 35,963 participants had data specific for
sleep duration and 26,344 participants of these participants were included in the analysis
portion of this meta-analysis. This drop-in participants from 48,360 to 26,344 occurred
because the studies analyzed other sleep characteristics so there were some participants
without information on sleep duration. The drop was also due to the use of only the highest
and lowest sleep duration category in relation to the reference category. For the definition of
sleep, there were four studies that defined sleep as night time sleep using a question such as
“how many hours do you usually sleep at night” while seven studies defined sleep as the
amount of sleep in a day by asking questions such as “how many hours on average do you
sleep per day” (Appendix A). Three of the studies looked at change in sleep duration while 9
studies looked at sleep duration. Out of the studies that looked at sleep duration five had the
outcome Alzheimer’s disease, 6 had the outcome dementia, and one had the outcome
vascular dementia. However, three of these studies categorized dementia as all-cause
dementia. From the studies that assessed change in sleep duration all three assessed the
outcome dementia while only 2 assessed Alzheimer’s disease. There were 3 studies that
defined sleep duration as sleep in a 24-hour period and 7 studies that defined sleep duration
as time in bed. There were five studies which included assessment of sleep duration during
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mid-life (35-64) and six studies which assessed sleep duration during late life (65+). The
study characteristics can be found in Error! Not a valid bookmark self-reference..
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Table 1 Study Characteristics. This table displays the key characteristics of the studies that were used in the meta-regression as well as the
subgroup analysis.
Adjusted variables: Age (1) Sex (2) Education (3) Heart disease (4) Blood pressure (5) Hypertension (6) Stroke (7) Chronic obstructive pulmonary disease (8) Total supernatant cholesterol (9) Low-density
lipoprotein (10) High-density lipoprotein (11) hsCRP (12) Hyperlipidemia (13) Hypercholesterolemia (14) Diabetes (15) Obesity (16) Body mass index (17) Cancer history (18) APOE (19) Homocysteine (20) Creactive protein (21) Smoking (22) Alcohol (23) Physical activity (24) Mental health (25) Depression (26) Psychological distress (27) Hopelessness (28) Pain (29) Living arrangement (30) Life satisfaction (31)
Medication (32) Physical functional dependence (33) Night work status (34) Coffee consumption (35) Center (36) Follow-up time (37) Examination year (38)
AD: Alzheimer’s Disease (ref): Reference group NA: Not available
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Sleep Duration and Dementia
There were 9 studies that studied the association between sleep duration and a form of
dementia. All 9 studies accessed the association between long sleep duration and a form of
dementia while only 8 included the risk estimates for the association between short sleep
duration and a form of dementia.
Short duration of sleep was defined as less than 5 hours of sleep in 2 studies, less than
6 hours in 2 studies, less than 6.5 hours for one study, and less than 7 hours for 2 studies. For
short duration of sleep, all-cause dementia had a summary risk estimate of 1.18 (CI: 0.941.42) and an I2 of 31.6% (p=0.199) (Figure 2). Alzheimer’s disease had a summary risk
estimate of 1.01 (CI: 0.92-1.09) and an I2 of 10.0% (p=0.343) (Figure 2). There were only
two studies of non-Alzheimer’s dementia (1.08 CI: 0.30-1.86) and one study of vascular
dementia (4.04 CI: -1.61-9.69) so a summary risk estimate could not be calculated for these
two forms of dementia (Figure 2). The p-values of the meta-regression were all above the
0.05 significance level. The subgroup analysis found that all variables of interest contained 1
in their confidence interval, except for dementia studies with both genders in their cohort
(1.43 CI: 1.03-1.83). The results of the meta-regression and subgroup analysis can be found
in Appendix C. When determining publication bias in the studies that assessed the
association between short sleep duration and incident dementia the Egger’s regression had a
p-value of 0.799 and the funnel plot was symmetrical (Appendix E). For studies that assessed
the association between short sleep duration and Alzheimer’s disease the Egger’s regression
had a p-value of 0.003 and an asymmetrical funnel plot (Appendix E).
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Figure 2 Forest plot for short duration of sleep and the different forms of dementia. Using the
fixed effects model. The risk estimates for each individual study represent the
shortest duration of sleep compared to the reference group.

Long duration of sleep was considered as more than 9 hours of sleep in 6 studies,
more than 8 hours of sleep in one study, and 10 or more hours of sleep in one study.
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Dementia had a summary risk estimate of 1.19 (CI: 0.90-1.48) and an I2 of 37.1% (p=0.146)
(Figure 3). Alzheimer’s disease had a summary risk estimate of 1.32 (CI: 0.92-1.72) and an I2
of 16.3% (p=0.065) (Figure 3. Forest plot for the association of long duration of sleep and the
different forms of dementia. Figure 3). The summary effect measures for non-Alzheimer’s
disease dementia was 1.33 (CI: 0.36-2.30). There was only one study that assessed vascular
dementia. The results of the meta-regression revealed that all variables of interest had pvalues greater than 0.05 except for the variable time of follow-up (p=0.02) for dementia
(Appendix D). The subgroup analysis found that most of the variables of interest contained
one in their confidence interval. However, the confidence interval did not include one for
studies that assessed dementia that had both genders in the cohort (1.22 CI: 1.04-1.39),
duration of follow up that was less than 10 years (2.54 CI: 1.07-4.00), duration of follow up
was between 10-19 years (1.21 CI: 1.03-1.38), ascertained sleep at early mid-life (1.27 CI:
1.02-1.53), and did not include mild cognitively impaired individuals at baseline (1.19
CI:1.01-1.38). For studies that assessed Alzheimer’s disease, those that defined sleep as time
in 24-hour sleep (1.79 CI: 1.11-2.47) and had less than 200 cases of Alzheimer’s disease
(1.75 CI: 1.16-2.35) had confidence intervals that did not include 1. The results of the metaregression and subgroup analysis can be found in Appendix D. The studies that focused on
long duration of sleep and dementia had an Egger’s regression p-value of 0.201 and a
symmetrical funnel plot (Appendix E). The studies that focused on long duration of sleep and
Alzheimer’s disease had a p-value of 0.022 and an asymmetrical funnel plot (Appendix E).
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Figure 3. Forest plot for the association of long duration of sleep and the different forms of
dementia. Using the random effects model.
Change in Sleep Duration
There were 3 studies that studied the association between change in sleep duration
and a form of dementia.
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Sleep reduction was defined as two or more hours of reduced sleep in two studies and
a change of sleep duration from more than 9 hours to less than 9 hours in one study. The
association between reduction of sleep duration and dementia had a summary risk estimate of
1.19 (CI: 0.79-1.68) and an I2 of 21.9% (Figure 4). For Alzheimer’s disease, the summary
risk estimate was 1.65 (CI: 0.67-2.63) and I2 was 0% (Figure 4). When assessing the
publication bias of these three studies the Egger’s regression p-value was 0.497 and the
funnel plot was symmetrical. When assessing publication bias in studies that assessed the
association between reduced sleep and dementia the funnel plot was symmetrical. There was
only one study that assessed the association between reduced sleep and Alzheimer’s disease
(Appendix E). There was insufficient data for a meta-regression.
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Figure 4. Forest plot for the association between sleep reduction and the different forms of
dementia. Using the random effects model.
Increase in sleep duration was defined as an increase of sleep by 2 hours or more in
two studies while one study defined increased sleep as a change of sleep duration from less
than 9 hours of sleep to 9 or more hours of sleep (Error! Not a valid bookmark selfreference.). There were two studies that looked at the association between increase in sleep
duration and incident dementia which resulted in a summary risk estimate of 2.11 (CI: 1.462.77) and an I2 of 0% (Figure 5). For Alzheimer’s disease, a summary risk estimate could not
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be calculated because there was only one study that assessed this association. Publication
bias could not be assessed for increase in sleep duration and Alzheimer’s disease because
there was only one study (Appendix E). The funnel plot for studies that assessed the
association between increase in sleep and dementia was symmetrical (Appendix E). There
was insufficient data for a meta-regression.
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Figure 5. Forest plot for the association of increase of sleep duration and the different forms
of dementia. Using the random effects model.
Sensitivity Analysis
For the association between short duration of sleep and dementia the removal of the
study Sindi et al. gave a summary effect measure of 1.2741 (CI: 1.0091-1.5394). For the
association between long duration of sleep and dementia the removal of the study Luojus et
al. gave a summary effect measure of 1.2736 (CI: 1.0180-1.5291) while the removal of any
of the other studies still gave a summary effect measure with a CI which contained one. For
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the association between short duration of sleep and Alzheimer’s disease the removal of any
single study did not change the association and all confidence intervals still contained one.
For the association between long duration of sleep and Alzheimer’s disease the removal of
the study Larsson et al. gave a summary effect measure of 1.7516 (CI: 1.1567-2.3464) while
the removal of other studies did not shift the risk estimate’s confidence interval to make it
contain one. The results of the sensitivity analysis can be found in Error! Reference source
not found. and Error! Reference source not found..

Table 2. Sensitivity Analysis: The summary effect measure after the removal of a single
study. This sensitivity analysis showed the effect of removing a single study on the overall
summary effect measure for sleep duration and incident dementia or Alzheimer’s disease.
Original represents the original summary effect measure and confidence interval for each
association. ES represents effect measure while CI represents confidence interval. Red*
indicates statistical significance.
DISCUSSION
Sleep Duration
The results from the meta-analysis indicate that there is no significant association
between short or long sleep duration and any form of dementia. This differs from previous
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meta-analyses that found a summary effect measure that suggested association between
dementia and long duration of sleep (1.42 CI: 1.15-1.77) (Kim et al., 2016) and between
Alzheimer’s disease and both short (1.64 CI: 1.05-2.54) and long (2.19 CI: 1.08-4.46) sleep
duration (Wu & Sun & Tan, 2018). In addition, the dose-response meta-analysis, performed
in the two most recent meta-analyses, found that individuals reporting either long duration of
sleep or short duration of sleep were more likely to develop dementia/MCI than those with
normal sleep (Liang & Ling-Bo & Hao, 2018: Wu & Sun & Tan, 2018).
The difference in results for the association between Alzheimer’s disease and sleep
duration may be due to the inclusion of new studies that were not published by the time Wu
et al. completed their literature search. This is supported by the sensitivity analysis which
found that the association between long duration of sleep and Alzheimer’s disease would
become statistically significantly (1.7516 CI: 1.1567-2.3464) if Larrson, et al. was removed
(Error! Reference source not found.). This study was not in the previous meta-analyses
and contributed the greatest weight (28.63%) to the summary risk estimate for the association
and made it statistically insignificant (Figure 3). This study had one of the longer follow-up
times, 16 years, but what distinguishes it from other studies is that they accounted for the
reverse causation effect by excluding cases of Alzheimer’s disease five or ten years after
baseline. This time period is longer than the other studies which excluded cases up to three
years after the study was initiated. This study also had the largest sample size and highest
number of Alzheimer’s disease cases when compared to other studies that assessed sleep
duration and Alzheimer’s disease.
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Another explanation is that studies that looked at the Alzheimer’s disease outcome
and defined sleep duration by a 24-hour period were more likely to see significant results.
This was shown by subgroup analysis which found that studies that looked at the association
between long duration of sleep and Alzheimer’s disease and defined sleep duration in a 24hour period had a summary risk estimate of 1.79 (CI: 1.11-2.47), while studies that used time
in bed had a weaker risk estimate that was statistically non-significant (1.07 CI: 0.76-1.38)
(Appendix D). This could occur because a study of total daily sleep time found that people
who self-report long duration of sleep are more likely to complain of disrupted and poor
sleep than those who sleep 7-8 hours daily (Grandner & Kripke, 2004). As a result, a sleep
duration defined by a 24-hour hour period could capture sleep fragmentation or low-quality
sleep which have been associated with increased risk of dementia (Lim, et al., 2013).
However, the more plausible explanation is that Larsson et al. defined sleep as time in bed so
when this study was separated from studies that defined sleep duration in a 24-hour period it
results in a significant finding.
The removal of Sindi et al. resulted in a significant summary effect measure between
short duration of sleep and dementia (1.2741 CI: 1.0091-1.5394). The likely explanation is
that it was the only study to show a protective risk ratio (0.74 CI: 0.36-1.53) and it
contributed the third most weight (1.83%) in the dementia subcategory (Figure 2). While this
sample size was less than a quarter of the sample size of the other studies in the subgroup it
did have a smaller variance, which could be attributed to a greater number of cases.
However, this can only be assumed since the number of Alzheimer’s disease and dementia
cases was never stated.
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The association between dementia and long duration of sleep became significant with
the removal of Luojus et al. which resulted in a summary effect measure of 1.2736 (CI:
1.0180-1.5291) (Error! Reference source not found.). This was a study that was published
after the Kim et al. study but the impact of this study was surprising because this study only
carried 18.67% of the weight while Bokenberger et al. carried 36.49% of the weight.
However, it was also the only study that found that long duration of sleep was protective for
dementia (0.83 CI: 0.55-1.23) so its removal would likely shift the summary risk estimate to
the right. (Figure 3). It was also the only study that had an all-male cohort which explains the
results of subgroup analysis for gender (Appendix D). The study was also the only one that
had a follow-up longer than 20 years. Thus, its separation resulted in the subgroup analysis
finding that studies with less than 10 years of follow up (2.54 CI: 1.07-4.00) and follow up
between 10 to 19 years (1.21 CI: 1.03-1.38) were statistically significant (Appendix D). As a
result, it is likely the reason why the subgroup analysis and meta-regression suggested that
follow-up time could explain the heterogeneity and insignificant association for long duration
of sleep and dementia but not for other associations.
Change in Sleep Duration
This is the first meta-analysis to compile the results of studies that looked at the
association between change in sleep duration and the different forms of dementia. While
sleep reduction did not show any significant association with any form of dementia the
association between increase in sleep and dementia was found to be statistically significant
(2.11 CI: 1.46-2.77) (Figure 5). However, there were only two studies that assessed the
association between prolonged sleep duration and dementia which means that there is likely
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publication bias. However, the heterogeneity between the two studies was zero (Figure 5).
While these two studies had similar study characteristics for length of follow up and method
of sleep ascertainment they did have differences in how they categorized change in sleep and
their definition of sleep. The study Westwood et al. defined increase in sleep duration as
sleeping less than nine hours 13 years before baseline then more than 9 hours at baseline. The
study Lu et al. defined sleep increase as a 1-hour increase in sleep or more than 2 hours of
increase in sleep (Error! Not a valid bookmark self-reference.). However, for this analysis
only the risk estimate from the 2 hours of increase in sleep category was used.
To the authors’ knowledge, there is no well accepted hypothesis for why prolonged
sleep duration could be associated with dementia incidence even though biological
mechanisms have been proposed for reduced, short, and long duration of sleep. Reduced
sleep and short duration of sleep are believed to prevent beta-amyloid clearing which causes
beta-amyloid plaque build-up which is a defining characteristic of Alzheimer’s disease
(Spira, et al.,2013). Long duration of sleep has been associated with arterial stiffness
(Niijima, et al., 2016) and blood pressure variability (Nagai, et al., 2017) which increases the
risk of cardiovascular disease which is a known risk factor for dementia. However, one
possible explanation is that prolonged sleep could be a marker for early neurodegeneration
and not an actual cause of dementia (Westwood, et al., 2017). Another explanation is that the
immunomodulators such as interleukin-6 and C-reactive protein which have been associated
with dementia (Akiyama, et al., 2000), have also been shown to increase sleep duration and
fragmentation during infections so the relationship may be bi-directional (Imeri & Opp,
2009).
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Test of Heterogeneity
When assessing heterogeneity, The I2 statistics suggested low heterogeneity for short
sleep duration and dementia (31.6%) and Alzheimer’s disease (10.0%) (Figure 2). It also
suggested low heterogeneity for long sleep duration and the outcomes dementia (I2 =37.1%)
and Alzheimer’s disease (16.3%) (Figure 3). The meta-regression for long duration of sleep
and dementia suggest that the low heterogeneity could be explained by length of follow-up
(p=0.002). When the subgroup analysis was conducted for this association, the I2 statistics
were reduced to 0% when separating the results by duration of follow up between 1-9 years,
10-19 years, and 20+ years. (Appendix D).
Publication Bias
Publication bias was expected in this meta-analysis because it included very few
studies. However, the Egger’s regression and funnel plot only indicated publication bias in
the 5 studies that assessed the association between sleep duration and Alzheimer’s disease
and not the 7 studies that assessed the association between sleep duration and dementia
(Appendix E). The reason why no publication bias was detected could be a result of the small
number of studies which prevented the test from determining true asymmetry due to low
power (Higgins & Green, 2011).
Subgroup Analysis
Due to the small number of studies the results from the subgroup analysis should be
interpreted with caution. This is because when a variable was significant it was often only
significant for one or two of the associations but not for others. The variables with the most
consistency were gender and sleep duration categories. When subgrouping by gender, the
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summary effect estimate was significant in studies which had a mixed gender cohort that
assessed both long and short sleep duration and dementia. However, it is surprising that this
result was seen in dementia and not Alzheimer’s disease because females are more likely to
develop Alzheimer’s disease than males (Seshadri, et al., 1997), while males are more likely
to develop dementia with Lewy bodies than females (Nelson, et al., 2010). There was no allfemale cohort and only one male cohort, so this assumption cannot be verified. When
subgrouping by duration of follow-up, the summary effect estimate was significant in studies
that assessed long duration of sleep and dementia with 1-9 years of follow up (2.54 CI: 1.074.00) and 10-19 years of follow up (1.21 CI:1.03-1.38).
The results of the subgroup analysis for the inclusion of MCI at baseline were
surprising because the summary effect measure for studies of the association of dementia and
long sleep duration that did not have MCI at baseline was significant, while the studies that
possibly had MCI at baseline didn’t have a statistically significant summary effect measure
(Appendix D). This was unexpected because mild cognitively impaired individuals are more
likely to develop dementia. As a result, the subgroup analysis of studies that included MCI
participants should have had significant results rather than the studies that did not include
participants with MCI at baseline. However, this finding could be explained by the
Bokenberger, et al., 2017 study which found an association between long duration of sleep
and dementia because of their large number of participants and cases.
It is hypothesized that beta-amyloid accumulation can begin up to 20 years before the
onset of Alzheimer’s disease symptoms (Villemagne, et al., 2013). Since it is a suggested
biological pathway that links sleep duration to dementia it is important for sleep duration to
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be assessed before this accumulation is believed to begin. In the current research, only four
of the eleven studies have the capability for this assessment because they have a
measurement of sleep duration during mid-life (Larsson, et al., 2018: Luojus, et al., 2017:
Virta, et al., 2013: Westwood, et al., 2017). The summary effect estimate of these studies
suggests that there is no association between sleep duration and any form of dementia
(Appendix C). As a result, these results suggest that beta-amyloid accumulation due to short
sleep duration may not be a pathway between sleep and Alzheimer’s disease since early midlife sleep duration does not seem to increase disease risk. However, there were very few
studies that studied sleep between ages 40-55 so more studies need to be done to determine if
this is the case.
CONCLUSION
This meta-analysis suggests that there is no association between duration of sleep and
any form of dementia which differs from the findings of previous meta-analyses. The
analysis suggests that the difference could be a result of new studies that have longer follow
up time and to differences in sleep definition. This meta-analysis did find that the association
between prolonged sleep duration and dementia was statistically significant. However, this
association needs to be verified by more research since only 2 studies have looked at this
association.
The major limitation is that this study included very few studies. The funnel plots and
Egger's regression suggested publication bias which means that the inclusion of new studies
could possibility change the associations found in this study. The small number of studies
also made the interpretation of subgroup analyses difficult because the small number of
36

studies increased the chance of seeing an association even when there was truly no
association. It was difficult to discern if the significant result of the subgroup analysis was
due to the actual variable or simply due to chance because of other variables that were
included in the same paper. As a result, the conclusions from this study should be taken with
caution. Another major issue is that most of these studies used self-reported data for sleep
duration. While some studies attempted to use multiple questions to obtain data on sleep
duration others simply asked, “how much sleep do you normally get” (Appendix A). Thus, it
is likely that most studies suffer from reporting bias.
Another limitation of this study and the previous meta-analyses is the use of only the
risk estimates from the longest and shortest sleep categories (Appendix A). This decreased
the power of the findings because there were less participants in these categories and thus
fewer cases. However, since these risk estimates were mostly hazard ratios there was no
method available to combine categories, so this method was used at the recommendation of
the Cochrane handbook (Higgins & Green, 2011).
The strength of this study is that it included more studies than the previous metaanalyses. This meta-analysis also only included studies that looked at the various forms of
dementia without MCI. These studies had longer lengths of follow-up than the studies in the
previous meta-analyses and they included non-Caucasian groups which was a limitation of
previous meta-analyses. Even though the major limitation was the small number of studies it
did allow the investigators to thoroughly read and understand all articles to try to find
explanations for the differences in study results.
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Recommendations for future studies would be to create a more accurate method for
sleep duration ascertainment. While polysomnography would be the gold standard it would
be difficult and costly for large cohorts an alternative might be fitness trackers that can
record the duration of sleep. However, a more reasonable method would be to use multiple
questions to obtain more accurate measures of sleep since many of these studies only used
one question to determine sleep duration (Appendix A). Other recommendations include
studying the effects of sleep duration at mid-life since the hypothesized beta-amyloid
accumulation pathway is believed to start 20 years before the actual onset of Alzheimer’s
disease and for studies to stratify data on baseline cognitive status.
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APPENDICES

Appendix A. Characteristics and risk estimates of sleep categories. The question used to
determine the sleep duration exposure, the number of participants per sleep category, and the
risk estimates associated with each categories of sleep duration.
Bold: Represents the risk estimate that was used in the analyses, Red: Represents results of
the specific study that were significant, Ref: Reference group, LC: Left censored by three
years, W/MCI: With MCI participants, NA: Not available, PY: Person Years
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Appendix B. Sensitivity analysis: These graphs show visualization of the summary effect
measure when the specific study is excluded a) The summary effect measure for short sleep
duration and Alzheimer’s disease b) The summary effect measure for long duration of sleep
and Alzheimer’s disease c) The summary effect measure for short duration of sleep and
dementia d) the summary effect measures for long sleep duration and dementia.
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Appendix C. Subgroup analysis and meta-regression for short duration of sleep. Red*
indicates statistical significance. ES represents the effect size for the association based on the
subgroup. The I2 represents the heterogeneity and P (Heterogeneity) is the p-value associated
with the percent heterogeneity from the I2 statistics for the specific sub-group. The P (Metaregression) represents the p-value for the meta-regression of the specific variable.
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Appendix D. Subgroup analysis and meta-regression for long duration of sleep. Red*
indicates statistical significance. The I2 represents the heterogeneity and P (Heterogeneity) is
the p-value associated with the percent heterogeneity from the I2 statistics for the specific
subgroup. The P (Meta-regression) represents the p-value for the meta-regression of the
specific variable.
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Appendix E. The results of the funnel plots to determine publication bias. A)The funnel plot
representing studies that assessed the assocation between Alzheimer’s disease and short
duration of sleep. B) The funnel plot representing studies that assessed the assocation
between Alzheimer’s disease and long duration of sleep. C) The funnel plot representing
studies that assessed the assocation between dementia and short duration of sleep D) The
funnel plot representing studies that assessed the assocation between dementia and long
duration of sleep. E) The funnel plot representing studies that assessed the assocation
between decreased sleep and Alzheimer’s disease. F) The funnel plot representing studies
that assessed the assocation between increase in sleep and Alzheimer’s disease. G) The
funnel plot representing studies that assessed the assocation between decreased sleep and
dementia. H) The funnel plot representing studies that assessed the assocation between
increase in sleep and dementia.
Study
Benito-Leon et al.,
2009
Virta et al., 2013
Hahn, et al., 2014
Bokenberger et al.,
2017
Luojus et al., 2017
Westwood et al., 2017
Larsson et al., 2018
Lu et al., 2018
Lutsey et al., 2018
Ohara, et al., 2018
Sindi et al., 2018
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Appendix F. Quality scores of the eleven studies using the Ottawa Quality Assessment Scale.
A quality score of 0-3 represents a low-quality score, 4-6 represents moderate quality, and 744

9 represents high quality. The quality score is made up scores from how they selected their
sample (0-4 stars), how the study was comparable to other studies based on variables they
adjusted for (0-2 stars), and factors concerning the outcome (0-3 stars).
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